← Back to Search

Contact Lenses

Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses

N/A
Waitlist Available
Research Sponsored by CooperVision International Limited (CVIL)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
No Placebo-Only Group

Summary

Bilateral dispensing study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric lenses

Eligible Conditions
  • Astigmatism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comfort
Dryness
Lens Preference With Respect to Overall Comfort
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyDay ToricExperimental Treatment1 Intervention
Participants were randomized to wear a new pair of MyDay Toric lenses each day for one week during the cross over study
Group II: 1-Day Acuvue Moist for AstigmatismActive Control1 Intervention
Participants were randomized to wear a new pair of 1-Day Acuvue Moist Toric lenses each day for one week during the cross over study
Group III: Dailies Aquacomfort Plus ToricActive Control1 Intervention
Participants were randomized to wear a new pair of Dailies Aquacomfort Plus Toric lenses each day for one week during the cross over study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyDay Toric
2023
N/A
~90

Find a Location

Who is running the clinical trial?

CooperVision International Limited (CVIL)Lead Sponsor
163 Previous Clinical Trials
14,121 Total Patients Enrolled
35 Trials studying Astigmatism
1,484 Patients Enrolled for Astigmatism
Coopervision, Inc.Lead Sponsor
163 Previous Clinical Trials
14,136 Total Patients Enrolled
35 Trials studying Astigmatism
1,484 Patients Enrolled for Astigmatism
~7 spots leftby Dec 2025